반응식
Br[C:2]1[C:7]([F:8])=[N:6][C:5]([C:9]2[CH:14]=[CH:13][C:12]([C@H:15]3[CH2:20][CH2:19][C@H:18]([CH2:21][CH2:22][CH2:23][CH2:24][CH3:25])[CH2:17][CH2:16]3)=[CH:11][CH:10]=2)=[CH:4][N:3]=1.[CH2:26]([Mg]Br)[CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH3:33]>>[F:8][C:7]1[C:2]([CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH3:33])=[N:3][CH:4]=[C:5]([C:9]2[CH:14]=[CH:13][C:12]([C@H:15]3[CH2:20][CH2:19][C@H:18]([CH2:21][CH2:22][CH2:23][CH2:24][CH3:25])[CH2:17][CH2:16]3)=[CH:11][CH:10]=2)[N:6]=1참가 물질
3
실험 절차
In an analogous reaction to Example 1d, 2.75 g (6.80 mmol) of 2-bromo-3-fluoro-5-[4-(trans-4-pentylcyclohexyl)phenyl]pyrazine and 10.2 mmol of octylmagnesium bromide give 1.53 g of 2-fluoro-3-octyl-6-[4-(trans-4-pentylcyclohexyl)phenyl]pyrazine. ##STR21## The compound has the following phase sequence:
출처 및 근거
- ORD 기록
- ord-2c45862eb187419694f22d5a9f2e5b50
- 출처 데이터셋
- uspto-grants-1996_10
- 특허 번호
- US05562859
연결된 노트
불러오는 중…